State Price Transparency legislation is a response to the industry trend of increasing Wholesale Acquisition Cost (WAC) prices and the lack of public knowledge around the reasoning for those increases. Individual states have taken it upon themselves to take legislative action in order to raise awareness for drug pricing trends over time allowing more accurate cost forecasts for state budgets.

Download our datasheet for more information on the solutions we provide to achieve operational excellence and reduce compliance risk around state price transparency.

Want a bit more information from our experts on state-by-state guidelines, or what manufacturers can do to comply with existing laws? Our advisory team goes in-depth during our Current State of Drug Pricing Transparency webinar.